Lamisil AT — Class III drug recall D-420-2013
Terminated recall by Novartis Consumer Health, reported 2013-05-29, distributed nationwide. Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the tube may not
| Recall number | D-420-2013 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Novartis Consumer Health, Lincoln, NE, United States |
| Recall initiated | 2013-04-19 |
| Classified | 2013-05-17 |
| Reported by FDA | 2013-05-29 |
| Terminated | 2014-11-04 |
| Distributed | Nationwide (US) |
| Quantity | 3,828 tubes |
| Reason classes | labeling |
| NDC | 00067-6171-85 |
| Lot numbers | 10118124 |
| Expiration dates | 2013-09-20 |
Product
Lamisil AT (terbinafine hydrochloride cream 1% antifungal), 24 g (.85 oz) tube, Novartis Consumer Health, Parsippany, NJ 07054, NDC 0067-6171-85
Reason for recall
Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the tube may not be legible in this lot.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-420-2013. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.